ALKBH5 and cholangiocarcinoma: ALKBH5 has been reported to maintain PD-L1 expression through the ALKBH5-PD-L1 regulatory axis in intrahepatic cholangiocarcinoma while inhibiting T-cell growth and infiltration [141].